CDKN2A and infection: At 4 weeks post-infection, the B6 Arf-/- recipient mice developed severe Lyme arthritis if they received splenocytes from B6.C3-Bbaa1 mice, but not from B6 or B6 Arf-/- mice (Fig 6D).